Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake

NCT02883166 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Radboud University Medical Center